Fred M. Powell - Jun 10, 2021 Form 4 Insider Report for ANTARES PHARMA, INC. (ATRS)

Signature
/s/Lisa M. Kallebo as attorney-in-fact for Fred M. Powell
Stock symbol
ATRS
Transactions as of
Jun 10, 2021
Transactions value $
$250,030
Form type
4
Date filed
6/14/2021, 06:24 PM
Previous filing
Jun 10, 2021
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRS Common Stock Award $380K +86K +12.2% $4.42 791K Jun 10, 2021 Direct F1
transaction ATRS Common Stock Tax liability -$77.1K -17.3K -2.19% $4.45 774K Jun 13, 2021 Direct F2
transaction ATRS Common Stock Tax liability -$52.9K -11.9K -1.54% $4.45 762K Jun 13, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRS Stock Option (right to buy) Award $0 +164K $0.00 164K Jun 10, 2021 Common Stock 164K $4.42 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
F2 Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
F3 Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
F4 The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.